![](https://www.petgazette.biz/wp-content/uploads/2023/08/james-lacy-xe_MtM-ixlw-unsplash-scaled-e1692372103113-780x470.jpg)
PetMedix, a UK-based biotech company discovering species-specific therapeutic antibodies for pets, has announced that it has been acquired by animal health company Zoetis.
You'll need to
subscribe to unlock this content. Already subscribed? Login?
Become a member for unlimited access
Remove all content restrictions with a membership account. First-year special offer pricing. Cancel any time.
You have read 2/2 free articles this month.
Person
Monthly
5 days free trial
Yearly
Save ยฃ9.89
5 days free trial
No, thanks
I already have an account
PetMedix, a UK-based biotech company discovering species-specific therapeutic antibodies for pets, has announced that it has been acquired by animal health company Zoetis.